Citation Impact
Citing Papers
The Mechanical Rigidity of the Extracellular Matrix Regulates the Structure, Motility, and Proliferation of Glioma Cells
2009
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
MRI detection of single particles for cellular imaging
2004
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab′)2 Uptake in SKBR3 Tumor Xenografts
2012
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Inhibition of Tumor Growth and Angiogenesis by Soluble EphB4
2004
EGFR Antagonists in Cancer Treatment
2008 Standout
Single-vector inducible lentiviral RNAi system for oncology target validation
2009
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Molecular magnetic resonance imaging with targeted contrast agents
2003
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
2006
Hypoxia-inducible Transcription Factor-2α in Endothelial Cells Regulates Tumor Neovascularization through Activation of Ephrin A1
2008
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
2009 StandoutNature
Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity
2013
Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: Implications for enhanced local drug delivery
2005
The αvintegrin antagonists as novel anticancer agents: an update
2002
Imaging in the era of molecular oncology
2008 StandoutNature
Integrin αβ3-Targeted Imaging of Lung Cancer
2005
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Eph receptor signalling casts a wide net on cell behaviour
2005
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
2005
Amyotrophic lateral sclerosis
2011 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Inhibition of Tumor Growth and Angiogenesis by Soluble EphB4
2004
Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors
2003
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Cancer nanotechnology: opportunities and challenges
2005 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Nanoparticle Imaging of Integrins on Tumor Cells
2006
Nanotheranostics for personalized medicine
2012
Polycomb Group proteins: an evolutionary perspective
2007
Malignant Gliomas in Adults
2008 Standout
Eph-modulated Cell Morphology, Adhesion and Motility in Carcinogenesis
2005
Hypoxic gene expression and metastasis
2004
Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation
2008
A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis
2005
Redirecting lipoic acid ligase for cell surface protein labeling with small-molecule probes
2007 StandoutNobel
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
2010
Angiogenic Signalling Pathways
2008
Imaging of angiogenesis: from microscope to clinic
2003
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
2007
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Specific E-selectin targeting with a superparamagnetic MRI contrast agent
2006
C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI
2005
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
The Polycomb complex PRC2 and its mark in life
2011 StandoutNature
Tumorigenesis and the angiogenic switch
2003 Standout
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Life with Oxygen
2007 StandoutScienceNobel
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display
2006
Lanthanide Luminescence for Biomedical Analyses and Imaging
2010 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents
2005
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Magnetic and Fluorescent Nanoparticles for Multimodality Imaging
2007
Nanoparticles in Photodynamic Therapy
2015 Standout
Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads
2020
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Nanotheranostics for personalized medicine.
2012
Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression
2007
Self-Assembled Virus-like Particles with Magnetic Cores
2007 StandoutNobel
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
2010
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Medulloblastoma Stem Cells
2008
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist
2004
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018
Works of Dowdy Jackson being referenced
EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma
2010
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
2009
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
2008
Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors
2003
A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth
2007
EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma
2009
Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles
2000
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
2002
A Human Antibody–Drug Conjugate Targeting EphA2 Inhibits Tumor GrowthIn vivo
2008
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo
2007
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib
2009
Contribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis
2007